Leclerc Foods has initiated a limited voluntary recall of a single lot of Fit & Active Chocolatey Chip Protein Meal Bars packages with UPC Code 41498-18695 and only affected products with a “best by” date of May 24, 2018.
Read The Complete Story!
All posts by admin
Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination
Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) is voluntarily recalling two lots of Riomet® (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet® (Metformin Hydrochloride Oral Solution) has been found to be contaminated (Scopulariopsis brevicaulis). The contamination was discovered during sample preparation for the Antimicrobial Preservative Effectiveness Testing (AMPET) being performed as part of the 12 month stability study interval.
Food Co. Issues Allergy Alert on Undeclared Allergen (E.G. Milk) in Product
Colorado Nut Company of Denver, CO is recalling Cashew Cranberry Cherry Jubilee, Oat Bran Nutty Crunch, Honey Nutty Granola, Peanut Delight, and Frontier Trail Mix, because they may contain undeclared Milk. People who have an allergy or severe sensitivity to Milk run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients
FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
FDA approves first two-drug regimen for certain patients with HIV
FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.
Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse
FDA Commissioner on steps to promote development of generic versions of opioids formulated to deter abuse
Goya Voluntary Recall of Adobo Because of Possible Health Risk
Goya de Puerto Rico is recalling 28 ounces Adobo with Cumin
Seasoning and 28 ounces Adobo with Pepper Seasoning because
they have the potential to be contaminated with Salmonella, an
organism which can cause serious and sometimes fatal infections
in young children, frail or elderly people, and others with weakened
immune system.
Casa Sanchez Foods Extiende El Retiro Voluntario Del " Real Guacamole " Para Incluir “Spicy Guacamole” Del Mercado Por Causa De Posible Riesgo Para La Salud
Casa Sanchez Foods de Hayward, California, está retirando todo su “Real Guacamole” y “Spicy Guacamole” del mercado, por precaución de acuerdo con el compromiso de la compañía para proteger la salud pública. La retirada fue necesaria por los resultados de pruebas positivas para Listeria monocytogenes en dos paquetes de muchas muestras recogidas para el programa de pruebas de muestras aleatorias de la Administración de Drogas y Alimentos de EE. UU.
Expanded Voluntary Recall for Casa Sanchez Foods "Real Guacamole" and to also Include “Spicy Guacamole” Because of Possible Health Risk
Casa Sanchez Foods of Hayward, CA, is voluntarily recalling all “Real Guacamole” and “Spicy Guacamole” products out of an abundance of caution in keeping with the company’s commitment to protect the public health. The recall was necessitated by positive test results for Listeria monocytogenes on two packages out of many samples collected for the U. S. Food and Drug Administration random sample testing program.
FDA approves first telehealth option to program cochlear implants remotely
FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.